Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06096090 |
|---|---|
| Brief Title: | Phase II Clinical Trial of Interleukin-2 in AD |
| First Submitted : | October 17, 2023 |
| First Submitted that Met QC Criteria : | October 17, 2023 |
| First Posted : | October 23, 2023 |
| Last Update Submitted that Met QC Criteria : | December 5, 2023 |
| Last Update Posted : | December 7, 2023 |